Vitamin C inhibits SARS coronavirus-2 main protease essential for viral replication

5/3 In Silico

Malla et al., bioRxiv, doi:10.1101/2021.05.02.442358 (Preprint)
Vitamin C inhibits SARS coronavirus-2 main protease essential for viral replication

Source PDF Share Tweet

In Vitro study showing that vitamin C inhibits SARS-CoV-2 3CLpro. Authors note that the different clinical results may be explained in part by the widely varying dosages used, and they conclude that vitamin C and/or derivatives may become an important treatment for COVID-19 and other viral infections.

Malla et al., 5/3/2021, preprint, 9 authors.

All 26 studies All Outcomes

Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC.

Submit